E.C. Can Improve R&D Investments For Poverty-Related, Neglected Diseases In 5 Ways

Devex: How the European Commission can boost its global health R&D investments
Sabine Campe, associate director at SEEK Development, and Nick Chapman, director of research at Policy Cures

“…[The European Commission] funds R&D for poverty-related and neglected diseases in much the same way as it funds R&D for other diseases. But the nonprofit nature of these diseases means that what is suitable for diseases with commercial markets can be problematic for R&D on poverty-related and neglected diseases. SEEK Development studied the commission’s funding mechanisms, and have five recommendations for how it can improve its investments: 1. Develop a clear funding strategy for global health R&D. … 2. Fund the entire research cycle. … 3. Relax eligibility requirements to support product developers with necessary expertise. … 4. Ensure new health tools will reach patients and achieve impact. … 5. Leverage the public-private partnership model of IMI…” (3/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.